A disintegrin and metalloproteinase domain 17-epidermal growth factor receptor signaling contributes to oral cancer pain-Reference-Cited by-同舟云学术

A disintegrin and metalloproteinase domain 17-epidermal growth factor receptor signaling contributes to oral cancer pain

Published:2020-05-19 Issue:10 Volume:161 Page:2330-2343
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:PAIN

Author:

Scheff Nicole N.,Ye Yi,Conley Zachary R.,Quan Jen Wui,Lam Yat Vong Ronald,Klares Richard,Singh Kamalpreet,Schmidt Brian L.,Aouizerat Bradley E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference88 articles.

1. Association of interleukin-6 and other cytokines with self-reported pain in prostate cancer patients receiving chemotherapy;Al-Mazidi;Pain Med,2018

2. Gene ontology: tool for the unification of biology: The Gene Ontology Consortium;Ashburner;Nat Genet,2000

3. NCBI GEO: archive for functional genomics data sets—update;Barrett;Nucleic Acids Res,2013

4. Changes in epidermal growth factor receptor gene copy number during oral carcinogenesis;Bates;Cancer Epidemiol Biomarkers Prev,2016

5. Profile of past and current clinical trials involving endothelin receptor antagonists: the novel “-sentan” class of drug;Battistini;Exp Biol Med (Maywood),2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain;Cell Communication and Signaling;2024-08-27

2. Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance;Pharmaceuticals;2023-11-03

3. Sex-dependent differences in the genomic profile of lingual sensory neurons in naïve and tongue-tumor bearing mice;Scientific Reports;2023-08-12

4. Sex-dependent Differences in the Genomic Profile of Lingual Sensory Neurons in Naïve and Tongue-Tumor Bearing Mice;2023-01-17

5. Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer;BMC Cancer;2022-11-11